New

Turn ETF ideas into real portfolios. Try the builder now →

Advertisement
Advertisement

PTHvsXBIETF Comparison

ETF 1
PTH

Invesco DWA Healthcare Momentum ETF

This fund is part of
US Health Care
-1.08%
VS
ETF 2
XBI

State Street SPDR S&P Biotech ETF

This fund is part of
US Health Care
-1.08%

Invesco DWA Healthcare Momentum ETF (PTH) and State Street SPDR S&P Biotech ETF (XBI) belong to the same industry segment: US Health Care. Both ETFs have the same top 3 sector exposures: and Health Care. PTH is more expensive with a Total Expense Ratio (TER) of 0.72%, versus 0.35% for XBI. PTH is up 4.86% year-to-date (YTD) with -$6M in YTD flows. XBI performs better with 9.28% YTD performance, and -$19M in YTD flows. Run a side-by-side ETF comparison of PTH and XBI below, and assess how they stack up in performance, liquidity, risk, exposure, holdings, and more, helping you select the best ETF for your investments.

Find out how industry players manage ETF portfolios.  Discover our library of Model portfolios

PTH vs XBI performance and flow charts

Performance

051015%Mar 24Mar 31Apr 8Apr 15Apr 22

Cumulative Flows

-600 M-400 M-200 M0 M200 M400 M600 MMar 24Mar 31Apr 8Apr 15Apr 22

Get all the metrics on this page, and more, through a reliable ETF data feed

Daily, global ETF data for advanced analysis or integration into apps (API), from our partner Trackinsight.

Historic performance and flows
Data as of 04/24/2026
1M3MYTD1Y3Y5Y
Perf.
PTH
XBI
+12.30%+11.52%
+6.29%+4.22%
+4.86%+9.28%
+38.78%+65.29%
+31.58%+64.93%
+0.54%-3.74%
Flows
PTH
XBI
-$2M+$314M
-$5M-$560M
-$6M-$19M
-$10M+$404M
-$81M-$1.15B
-$357M+$839M
Volatility and drawdown
3M1Y3Y5Y
Volatility
PTH
XBI
+26.84%+30.22%
+22.82%+25.87%
+24.56%+27.40%
+25.26%+32.69%
Max drawdown
PTH
XBI
-7.51%-7.98%
-11.91%-9.66%
-29.24%-32.94%
-50.10%-55.10%
Max drawdown duration
PTH
XBI
40d42d
140d76d
271d331d
1695d1822d
Trading data

Create an account to view trading data

Join for free
PTH
XBI
Last sale
4/24/2026 at 1:30 PM
$52.13
$133.28
Previous close
04/23/2026
$52.31
$134.49
Consolidated volume
04/23/2026
Average volume
30 days
Average discount or premium
30 days
Average Bid/Ask spread
30 days
Replication quality
Data as of March 31, 2026
1-year trailing difference

Create an account to view replication metrics

Join for free

Create an account to view replication quality

Join for free
PTH
XBI
Tracking error
Tracking difference
1 year cumulative return difference
Best
Worst
Daily return difference
Average
Worst
Advertisement
Main metrics
Last update 4/24/2026 at 1:30 PM
Live
Closed
PTH
XBI
Last price
$52.13
$133.28
1D performance
-0.34%
-0.90%
AuM$125.11 M$8.52 B
E/R0.72%0.35%
Characteristics
PTH
XBI
Management strategyPassivePassive
ProviderInvescoState Street Investment Management
BenchmarkDorsey Wright Healthcare Technical Leaders IndexS&P Biotechnology Select Industry Index
N° of holdings46122
Asset classEquitiesEquities
Trailing 12m distribution yield
Join
Join
Inception dateOctober 12, 2006January 31, 2006
ESGNoNo
Advertisement
Exposure

Countries

PTH
USA
94.53%
Other
5.47%
XBI
USA
95.16%
Other
4.84%

Sectors

PTH
Health Care
85.2%
Other
14.8%
XBI
Health Care
86.79%
Other
13.21%
Advertisement

Diversification

PTH

Total weight of top 15 holdings out of 15

52.67%
XBI

Total weight of top 15 holdings out of 15

19.71%

Top 15 holdings

Data as of March 31, 2026
PTH
TERNS PHARMACEUTICALS
6.73%
ROIVANT SCIENCES LTD
5.47%
US74006W2070
5.15%
ARROWHEAD PHARMACEUTICALS INC
3.66%
GUARDANT HEALTH INC
3.47%
REVOLUTION MEDICINES INC
3.32%
TENET HEALTHCARE
3.16%
UTD THERAPEUT
2.99%
NATERA
2.95%
HCA HEALTHCARE
2.89%
CELCUITY INC
2.88%
AXSOME THERA CMN STK
2.58%
MADRIGAL PHARMACEUTICALS INC
2.58%
PROTAGONIST THERAPEUTICS INC
2.43%
COGENT BIOSCIENCES
2.40%
XBI
APELLIS PHARMACEUTICALS
1.83%
ALKERMES
1.45%
MADRIGAL PHARMACEUTICALS INC
1.38%
TG THERAPEUTICS
1.35%
INSMED
1.34%
SCHOLAR ROCK HOLDING CORP
1.30%
US03770N1019
1.28%
PROTAGONIST THERAPEUTICS INC
1.25%
US86627T1088
1.24%
UTD THERAPEUT
1.24%
US74006W2070
1.24%
ARROWHEAD PHARMACEUTICALS INC
1.23%
COGENT BIOSCIENCES
1.22%
BRIDGEBIO PHARMA
1.19%
PTC THERAPEUTI/D
1.18%
Frequently asked questions about PTH and XBI

How have the PTH and XBI ETFs performed in 2026?

As of April 24, 2026, PTH is up 4.86% year-to-date (YTD), while XBI has returned 9.28%. That puts XBI better performer ahead so far this year.

Which ETF is attracting more investor money: PTH or XBI?

Year-to-date, the PTH ETF saw -$6M in flows, compared to -$19M for XBI.

Which ETF is more volatile: PTH or XBI?

Over the past year, PTH had a volatility of 22.82%, while XBI experienced 25.87%.

Which ETF is bigger: PTH or XBI?

As of April 24, 2026, PTH holds $125.11 M in assets under management (AUM), while XBI manages $8.52 B.

What sectors do the PTH and XBI ETFs invest in?

PTH leans toward sectors like Health Care. Meanwhile, XBI focuses on Health Care.

What are the top holdings of the PTH ETF and XBI ETF?

PTH top holdings include TERNS PHARMACEUTICALS, ROIVANT SCIENCES LTD and US74006W2070. XBI holds in its top three: APELLIS PHARMACEUTICALS, ALKERMES and MADRIGAL PHARMACEUTICALS INC.

Which ETF is more diversified: PTH or XBI?

PTH holds 57 securities with 52.67% of its assets in the top 15. XBI has 151 securities and a top 15 weight of 19.71%.

Advertisement
Advertisement
Advertisement
Webcast on Demand

Calamos Investments Powers the Next Phase of the Autocallable Revolution

Join J.P. Morgan’s Bram Kaplan, Head of Americas Equity Derivatives Strategy and Matt Kaufman from Calamos Investments as they dive into the growing global opportunity in autocallable income—an increasingly dominant strategy within structured products, now available through ETFs.

Accepted for 1 CE Credit

Calamos Webcast